{"id":730075,"date":"2023-02-09T07:29:35","date_gmt":"2023-02-09T12:29:35","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/renalytix-to-participate-in-the-btig-medtech-digital-health-life-science-diagnostic-tools-conference\/"},"modified":"2023-02-09T07:29:35","modified_gmt":"2023-02-09T12:29:35","slug":"renalytix-to-participate-in-the-btig-medtech-digital-health-life-science-diagnostic-tools-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/renalytix-to-participate-in-the-btig-medtech-digital-health-life-science-diagnostic-tools-conference\/","title":{"rendered":"Renalytix to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference"},"content":{"rendered":"
\n

LONDON and SALT LAKE CITY, Feb. 09, 2023 (GLOBE NEWSWIRE) — Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today announced the Company will be participating in the upcoming BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference, which takes place February 14-16, 2023 in Snowbird, Utah. Due to the format of this event there are no formal company presentations. Management will be participating in one-on-one meetings with investors during the event and meetings can be requested through BTIG (info@btig.com<\/a>).<\/p>\n

\n About Renalytix<\/strong>
\n
Renalytix (NASDAQ: RNLX) (LSE: RENX) is an in-vitro diagnostics and laboratory services company that is the global founder and leader in the new field of bioprognosis\u2122\u00a0for kidney health. The leadership team, with a combined 200+ years of healthcare and in-vitro diagnostic experience, has designed its KidneyIntelX laboratory developed test to enable risk assessment for rapid progressive decline in kidney function in adult patients with T2D and early CKD (stages 1-3). We believe that by understanding how disease will progress, patients and providers can take action early to improve outcomes and reduce overall health system costs. For more information, visit\u00a0www.renalytix.com<\/a>.<\/p>\n

\n
\n For further information, please contact:<\/em>
\n <\/strong>\n <\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n Renalytix plc <\/strong>\n <\/td>\n\n
\n www.renalytix.com<\/u>
\n <\/a>\n <\/td>\n<\/tr>\n
James McCullough, CEO<\/td>\n\n Via Walbrook PR <\/strong>\n <\/td>\n<\/tr>\n
\u00a0<\/td>\n\u00a0<\/td>\n<\/tr>\n
\n Stifel (Nominated Adviser, Joint Broker)<\/strong>\n <\/td>\n\n Tel: 020 7710 7600<\/strong>\n <\/td>\n<\/tr>\n
Alex Price \/ Nicholas Moore \/ Nick Harland \/ Samira Essebiyea<\/td>\n\u00a0<\/td>\n<\/tr>\n
\u00a0<\/td>\n\u00a0<\/td>\n<\/tr>\n
\n Investec Bank plc (Joint Broker)<\/strong>\n <\/td>\n\n Tel: 020 7597 4000<\/strong>\n <\/td>\n<\/tr>\n
Gary Clarence \/ Ben Farrow<\/td>\n\u00a0<\/td>\n<\/tr>\n
\u00a0<\/td>\n\u00a0<\/td>\n<\/tr>\n
\n Walbrook PR Limited<\/strong>\n <\/td>\n\n Tel: 020 7933 8780 <\/strong>or renalytix@walbrookpr.com<\/u><\/a><\/td>\n<\/tr>\n
Paul McManus \/ Lianne Applegarth<\/td>\nMob: 07980 541 893 \/ 07584 391 303<\/td>\n<\/tr>\n
\u00a0<\/td>\n\u00a0<\/td>\n<\/tr>\n
\n CapComm Partners<\/strong>\n <\/td>\n\u00a0<\/td>\n<\/tr>\n
Peter DeNardo<\/p>\n<\/td>\n\n Tel: 415-389-6400<\/strong> or investors@renalytix.com<\/u><\/a><\/td>\n<\/tr>\n<\/table>\n


\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

LONDON and SALT LAKE CITY, Feb. 09, 2023 (GLOBE NEWSWIRE) — Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today announced the Company will be participating in the upcoming BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference, which takes place February 14-16, 2023 in Snowbird, Utah. Due to the format of this event there are no formal company presentations. Management will be participating in one-on-one meetings with investors during the event and meetings can be requested through BTIG (info@btig.com). About Renalytix Renalytix (NASDAQ: RNLX) (LSE: RENX) is an in-vitro diagnostics and laboratory services company that is the global founder and leader in the new field of bioprognosis\u2122\u00a0for kidney health. The leadership team, with a combined 200+ years of healthcare and … <\/p>\n

Continue reading “Renalytix to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-730075","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nRenalytix to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/renalytix-to-participate-in-the-btig-medtech-digital-health-life-science-diagnostic-tools-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Renalytix to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"LONDON and SALT LAKE CITY, Feb. 09, 2023 (GLOBE NEWSWIRE) — Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today announced the Company will be participating in the upcoming BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference, which takes place February 14-16, 2023 in Snowbird, Utah. Due to the format of this event there are no formal company presentations. Management will be participating in one-on-one meetings with investors during the event and meetings can be requested through BTIG (info@btig.com). About Renalytix Renalytix (NASDAQ: RNLX) (LSE: RENX) is an in-vitro diagnostics and laboratory services company that is the global founder and leader in the new field of bioprognosis\u2122\u00a0for kidney health. The leadership team, with a combined 200+ years of healthcare and … Continue reading "Renalytix to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/renalytix-to-participate-in-the-btig-medtech-digital-health-life-science-diagnostic-tools-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-02-09T12:29:35+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0NTY5NCM1Mzk5Njg5IzIyMzM0MTI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/renalytix-to-participate-in-the-btig-medtech-digital-health-life-science-diagnostic-tools-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/renalytix-to-participate-in-the-btig-medtech-digital-health-life-science-diagnostic-tools-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Renalytix to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference\",\"datePublished\":\"2023-02-09T12:29:35+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/renalytix-to-participate-in-the-btig-medtech-digital-health-life-science-diagnostic-tools-conference\\\/\"},\"wordCount\":262,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/renalytix-to-participate-in-the-btig-medtech-digital-health-life-science-diagnostic-tools-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc0NTY5NCM1Mzk5Njg5IzIyMzM0MTI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/renalytix-to-participate-in-the-btig-medtech-digital-health-life-science-diagnostic-tools-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/renalytix-to-participate-in-the-btig-medtech-digital-health-life-science-diagnostic-tools-conference\\\/\",\"name\":\"Renalytix to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/renalytix-to-participate-in-the-btig-medtech-digital-health-life-science-diagnostic-tools-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/renalytix-to-participate-in-the-btig-medtech-digital-health-life-science-diagnostic-tools-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc0NTY5NCM1Mzk5Njg5IzIyMzM0MTI=\",\"datePublished\":\"2023-02-09T12:29:35+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/renalytix-to-participate-in-the-btig-medtech-digital-health-life-science-diagnostic-tools-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/renalytix-to-participate-in-the-btig-medtech-digital-health-life-science-diagnostic-tools-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/renalytix-to-participate-in-the-btig-medtech-digital-health-life-science-diagnostic-tools-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc0NTY5NCM1Mzk5Njg5IzIyMzM0MTI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc0NTY5NCM1Mzk5Njg5IzIyMzM0MTI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/renalytix-to-participate-in-the-btig-medtech-digital-health-life-science-diagnostic-tools-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Renalytix to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Renalytix to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/renalytix-to-participate-in-the-btig-medtech-digital-health-life-science-diagnostic-tools-conference\/","og_locale":"en_US","og_type":"article","og_title":"Renalytix to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference - Market Newsdesk","og_description":"LONDON and SALT LAKE CITY, Feb. 09, 2023 (GLOBE NEWSWIRE) — Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today announced the Company will be participating in the upcoming BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference, which takes place February 14-16, 2023 in Snowbird, Utah. Due to the format of this event there are no formal company presentations. Management will be participating in one-on-one meetings with investors during the event and meetings can be requested through BTIG (info@btig.com). About Renalytix Renalytix (NASDAQ: RNLX) (LSE: RENX) is an in-vitro diagnostics and laboratory services company that is the global founder and leader in the new field of bioprognosis\u2122\u00a0for kidney health. The leadership team, with a combined 200+ years of healthcare and … Continue reading \"Renalytix to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/renalytix-to-participate-in-the-btig-medtech-digital-health-life-science-diagnostic-tools-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2023-02-09T12:29:35+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0NTY5NCM1Mzk5Njg5IzIyMzM0MTI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/renalytix-to-participate-in-the-btig-medtech-digital-health-life-science-diagnostic-tools-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/renalytix-to-participate-in-the-btig-medtech-digital-health-life-science-diagnostic-tools-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Renalytix to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference","datePublished":"2023-02-09T12:29:35+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/renalytix-to-participate-in-the-btig-medtech-digital-health-life-science-diagnostic-tools-conference\/"},"wordCount":262,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/renalytix-to-participate-in-the-btig-medtech-digital-health-life-science-diagnostic-tools-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0NTY5NCM1Mzk5Njg5IzIyMzM0MTI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/renalytix-to-participate-in-the-btig-medtech-digital-health-life-science-diagnostic-tools-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/renalytix-to-participate-in-the-btig-medtech-digital-health-life-science-diagnostic-tools-conference\/","name":"Renalytix to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/renalytix-to-participate-in-the-btig-medtech-digital-health-life-science-diagnostic-tools-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/renalytix-to-participate-in-the-btig-medtech-digital-health-life-science-diagnostic-tools-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0NTY5NCM1Mzk5Njg5IzIyMzM0MTI=","datePublished":"2023-02-09T12:29:35+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/renalytix-to-participate-in-the-btig-medtech-digital-health-life-science-diagnostic-tools-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/renalytix-to-participate-in-the-btig-medtech-digital-health-life-science-diagnostic-tools-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/renalytix-to-participate-in-the-btig-medtech-digital-health-life-science-diagnostic-tools-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0NTY5NCM1Mzk5Njg5IzIyMzM0MTI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0NTY5NCM1Mzk5Njg5IzIyMzM0MTI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/renalytix-to-participate-in-the-btig-medtech-digital-health-life-science-diagnostic-tools-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Renalytix to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/730075","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=730075"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/730075\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=730075"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=730075"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=730075"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}